CU
Methodology breakdown computing — it will appear here on its own.
Curanex Pharmaceuticals Inc. (CURX) is currently considered not halal (non-compliant), per our secondary compliance provider (last assessed 2026-08-25). See the full ratio breakdown and business-activity screen below for the reasoning.
⚠️ Financial ratios are only half the screen. A company whose core business is in an excluded sector — weapons/defense, alcohol, gambling, conventional (interest-based) finance, tobacco, pork, or adult entertainment — is non-compliant even if every debt and income ratio passes. So passing ratios below don't override this verdict; check the business-activity screen for the reason.
Computing the full ratio and business-activity breakdown for CURX — this runs off the critical path so the page paints first. It will appear here on its own.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally above. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 45.80 | NEUTRAL |
| Stochastic %K (14) | 17.82 | BUY |
| CCI (20) | -102.31 | BUY |
| Williams %R (14) | -82.18 | BUY |
| MACD (12,26,9) | -0.02 | SELL |
| ROC (10) | -6.30 | SELL |
| Momentum (10) | -0.29 | SELL |
| EMA (10) | 4.58 | SELL |
| SMA (10) | 4.59 | SELL |
| EMA (20) | 4.56 | SELL |
| SMA (20) | 4.64 | SELL |
| EMA (30) | 4.56 | SELL |
| SMA (30) | 4.44 | SELL |
| EMA (50) | 4.75 | SELL |
| SMA (50) | 4.37 | SELL |
| EMA (100) | 5.89 | SELL |
| SMA (100) | 5.57 | SELL |
| EMA (200) | 9.24 | SELL |
| SMA (200) | 6.77 | SELL |
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
Healthcare · Biotechnology
Curanex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients with inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout. The company was formerly known as Fordman Pharma Inc. and changed its name to Curanex Pharmaceuticals Inc in November 2023. Curanex Pharmaceuticals Inc was founded in 1996 and is headquartered in Jericho, New York.
Background via Yahoo Finance — informational, not part of the verdict.
Good setup, solid confluence
| Timeframe | Bias | Bars |
|---|---|---|
| 📅 Daily | BEARISH | 61 |
| ⏰ 4H | NEUTRAL | 15 |
| 🕐 1H | BEARISH | 61 |
| ⏱ 15-Min | BEARISH | 130 |
| ⏲ 5-Min | BEARISH | 234 |
Peer movement computing — it will appear here on its own.
NO DATA 0 buys · 0 sells
NEUTRAL report date 2026-09-01 · Asset managers net 934180 (-19048)
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.
